Key result
E. coli Type I-E CRISPR spacers preferentially target host genomes over phages, suggesting endogenous gene regulation.
Why the study?
Type I-E CRISPR/Cas system in E. coli appears not to exhibit active adaptation to viral infections, suggesting possible non-immune functions.
p-value: p=≈ 0
The Type I-E CRISPR/Cas system in E. coli likely plays a major role in the transcription regulation of endogenous genes rather than just immune response.
Computational predictions of non-canonical CRISPR roles in E. coli remain hypothesis-generating; experimental validation needed before inferring function.
CRISPR/Cas is an adaptive bacterial immune system, whose CRISPR array can actively change in response to viral infections. However, Type I-E CRISPR/Cas in E. coli (an established model system), appears not to exhibit such active adaptation, which suggests that it might have functions other than immune response. Through computational analysis, we address the involvement of the system in non-canonical functions. To assess targets of CRISPR spacers, we align them against both E. coli genome and an exhaustive (~230) set of E. coli viruses. We systematically investigate the obtained alignments, such as hit distribution with respect to genome annotation, propensity to target mRNA, the target functional enrichment, conservation of CRISPR spacers and putative targets in related bacterial genomes. We find that CRISPR spacers have a statistically highly significant tendency to target (i) host compared to phage genomes, (ii) one of the two DNA strands, (iii) genomic dsDNA rather than mRNA, (iv) transcriptionally active regions, and (v) sequences (cis-regulatory elements) with slower turn-over rate compared to CRISPR spacers (trans-factors). The results suggest that the Type I-E CRISPR/Cas system has a major role in transcription regulation of endogenous genes, with a potential to rapidly rewire these regulatory interactions, with targets being selected through naïve adaptation.
No takes yet. Share an insight, caveat, or question.
Božić et al. (2019) studied E. coli Type I-E CRISPR/Cas system function. CRISPR spacer alignment against host genome vs. Alignment against phage genomes was evaluated on Alignment scores of CRISPR spacers (p=≈ 0). Type I-E CRISPR/Cas system spacers in E. coli showed a statistically highly significant tendency to target the host genome compared to phage genomes, suggesting a major role in endogenous gene regulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: